You may need to update your Flash Player to Flash 8+ to view this DELCATH Web Page.

 


For Patients

CURRENT TRIALS

Delcath Systems Inc.






OVERVIEW: Current Trials

Phase III - Treatment of Metastatic Melanoma in the Liver (Ocular and Cutaneous) with Melphalan, taking place at the National Cancer Institute
> Read More...

Phase II - Treatment of metastatic neuroendocrine tumors to the liver with Melphalan, taking place at the National Cancer Institute
> Read More...

Phase II - Treatment of metastatic adenocarcinoma tumors to the liver with Melphalan, taking place at the National Cancer Institute
> Read More...

Phase II - Treatment of hepatocellular carcinoma (primary liver cancer) with Melphalan, taking place at the National Cancer Institute
> Read More...

 

 

 

 

 

 

 

 


For any questions, please contact
Delcath Systems, Inc.
Rockefeller Center
600 Fifth Avenue, 23rd Floor
New York, NY 10020
Telephone: (212) 489-2100
Fax: (212) 489-2102


 

 
> Back To Top <


FOR PHYSICIANS
The Delcath System PHP

 
Publications

 
Current Trials

 
Contact Medical Director